# BROMFENAC SODIUM
> **ANDA206027** · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2023-11-22
## Drug
- **FDA Application Number:** ANDA206027
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BROMFENAC SODIUM
- **Generic name:** BROMFENAC SODIUM
- **Active ingredients:** BROMFENAC SODIUM
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** LUPIN
- **Manufacturer:** Lupin Pharmaceuticals, Inc.
- **First approval:** 2023-11-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206027)
---
*AI Analytics · CC0 1.0*